SI9300149B - Sestavki cepiv - Google Patents
Sestavki cepiv Download PDFInfo
- Publication number
- SI9300149B SI9300149B SI9300149A SI9300149A SI9300149B SI 9300149 B SI9300149 B SI 9300149B SI 9300149 A SI9300149 A SI 9300149A SI 9300149 A SI9300149 A SI 9300149A SI 9300149 B SI9300149 B SI 9300149B
- Authority
- SI
- Slovenia
- Prior art keywords
- hbsag
- hepatitis
- vaccine composition
- antigen
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929206789A GB9206789D0 (en) | 1992-03-27 | 1992-03-27 | Vaccine |
GB929206786A GB9206786D0 (en) | 1992-03-27 | 1992-03-27 | Vaccine |
GB929206797A GB9206797D0 (en) | 1992-03-27 | 1992-03-27 | Vaccine |
GB929206788A GB9206788D0 (en) | 1992-03-27 | 1992-03-27 | Vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
SI9300149A SI9300149A (en) | 1993-12-31 |
SI9300149B true SI9300149B (sl) | 2003-02-28 |
Family
ID=27450853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9300149A SI9300149B (sl) | 1992-03-27 | 1993-03-26 | Sestavki cepiv |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP0633784B2 (zh) |
JP (1) | JP3470719B2 (zh) |
KR (1) | KR100270134B1 (zh) |
CN (1) | CN1072963C (zh) |
AP (1) | AP570A (zh) |
AT (1) | ATE146678T1 (zh) |
AU (4) | AU3751693A (zh) |
CA (1) | CA2132833C (zh) |
CZ (1) | CZ283424B6 (zh) |
DE (1) | DE69306940T3 (zh) |
DK (1) | DK0633784T4 (zh) |
ES (1) | ES2098029T5 (zh) |
FI (1) | FI110843B (zh) |
GR (1) | GR3022174T3 (zh) |
HK (1) | HK1003218A1 (zh) |
HU (1) | HU221253B1 (zh) |
IL (1) | IL105161A (zh) |
MA (1) | MA22842A1 (zh) |
MY (1) | MY111880A (zh) |
NO (1) | NO309458B1 (zh) |
NZ (1) | NZ249868A (zh) |
RU (1) | RU2121849C1 (zh) |
SA (1) | SA93130573B1 (zh) |
SG (1) | SG48375A1 (zh) |
SI (1) | SI9300149B (zh) |
SK (1) | SK280160B6 (zh) |
UA (1) | UA44688C2 (zh) |
WO (1) | WO1993019780A1 (zh) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
CN1087176C (zh) * | 1993-03-23 | 2002-07-10 | 史密斯克莱·比奇曼生物公司 | 含有3-o脱酰基单磷酰脂a的疫苗制剂 |
US6488934B1 (en) | 1995-02-25 | 2002-12-03 | Smithkline Beecham Biologicals S.A. | Hepatitis B vaccine |
GB9503863D0 (en) * | 1995-02-25 | 1995-04-19 | Smithkline Beecham Biolog | Vaccine compositions |
GB9513261D0 (en) * | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
PL343429A1 (en) * | 1998-03-09 | 2001-08-13 | Smithkline Beecham Biolog | Combined vaccine compositions |
US6306404B1 (en) | 1998-07-14 | 2001-10-23 | American Cyanamid Company | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
EP2266604A3 (en) | 1998-10-16 | 2011-05-11 | GlaxoSmithKline Biologicals S.A. | Adjuvant systems and vaccines |
GB9822714D0 (en) * | 1998-10-16 | 1998-12-09 | Smithkline Beecham Sa | Vaccines |
FI108150B (fi) | 1999-02-15 | 2001-11-30 | Sulzer Pumpen Ag | Menetelmä ja laitteisto massan käsittelemiseksi |
US6635261B2 (en) | 1999-07-13 | 2003-10-21 | Wyeth Holdings Corporation | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US20080085289A1 (en) | 2004-09-22 | 2008-04-10 | Cindy Castado | Immunogenic Composition |
KR20070116650A (ko) | 2005-03-23 | 2007-12-10 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 조성물 |
CN102755645A (zh) | 2005-11-04 | 2012-10-31 | 诺华疫苗和诊断有限公司 | 佐剂配制的包含细胞因子诱导剂的流感疫苗 |
ES2377884T3 (es) | 2005-11-04 | 2012-04-02 | Novartis Vaccines And Diagnostics S.R.L. | Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores |
JP2009514838A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 細胞培養物において増殖されたインフルエンザウイルスから調製された非ビリオン抗原を含むアジュバントワクチン |
AU2006310163B2 (en) | 2005-11-04 | 2011-09-15 | Seqirus UK Limited | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
CA2808919C (en) | 2005-12-22 | 2016-04-19 | Glaxosmithkline Biologicals S.A. | Streptococcus pneumoniae capsular saccharide vaccine |
DK2478916T3 (da) | 2006-01-27 | 2020-06-15 | Seqirus Uk Ltd | Influenzavacciner indeholdende hæmagglutinin og matrixproteiner |
ES2376492T3 (es) | 2006-03-23 | 2012-03-14 | Novartis Ag | Compuestos de imidazoquinoxalina como inmunomoduladores. |
CA2646349A1 (en) | 2006-03-24 | 2007-10-04 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Storage of influenza vaccines without refrigeration |
AU2007233705B2 (en) | 2006-03-30 | 2010-12-23 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
US20100015168A1 (en) | 2006-06-09 | 2010-01-21 | Novartis Ag | Immunogenic compositions for streptococcus agalactiae |
WO2008009309A1 (en) | 2006-07-17 | 2008-01-24 | Glaxosmithkline Biologicals S.A. | Influenza vaccine |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
ES2694805T7 (es) | 2006-09-11 | 2021-10-21 | Seqirus Uk Ltd | Fabricación de vacunas contra virus de la gripe sin usar huevos |
SG177141A1 (en) | 2006-12-06 | 2012-01-30 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
PE20090146A1 (es) | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
DK2167121T3 (en) | 2007-06-26 | 2015-11-23 | Glaxosmithkline Biolog Sa | A vaccine comprising Streptococcus pneumoniae kapselpolysaccharidkonjugater |
EP2185191B1 (en) | 2007-06-27 | 2012-09-12 | Novartis AG | Low-additive influenza vaccines |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
WO2009081172A1 (en) | 2007-12-24 | 2009-07-02 | Novartis Ag | Assays for adsorbed influenza vaccines |
WO2010099580A1 (en) | 2009-03-05 | 2010-09-10 | Jenny Colleen Mccloskey | Treatment of infection |
ES2918381T3 (es) | 2009-07-15 | 2022-07-15 | Glaxosmithkline Biologicals Sa | Composiciones de proteína F de VRS y métodos para producir las mismas |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
CN103282375B (zh) | 2010-12-02 | 2017-01-11 | 比奥诺尔免疫有限公司 | 肽支架设计 |
MX346475B (es) | 2011-01-06 | 2017-03-22 | Bionor Immuno As | Peptidos inmunogenicos monomericos y multimericos. |
PT2667892T (pt) | 2011-01-26 | 2019-06-07 | Glaxosmithkline Biologicals Sa | Regime de imunização contra o vsr |
PT2707385T (pt) | 2011-05-13 | 2017-12-19 | Glaxosmithkline Biologicals Sa | Antigénios de f de rsv pré-fusão |
MX2014014683A (es) | 2012-06-06 | 2015-02-24 | Bionor Immuno As | Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion. |
KR20180035807A (ko) | 2015-06-26 | 2018-04-06 | 세퀴러스 유케이 리미티드 | 항원적으로 매치된 인플루엔자 백신 |
US20230109142A1 (en) | 2020-02-14 | 2023-04-06 | Immunor As | Corona virus vaccine |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584866D1 (de) * | 1984-09-12 | 1992-01-23 | Chiron Corp | Hybridpartikel-immunogene. |
HU220204B (hu) * | 1987-11-18 | 2001-11-28 | Chiron Corp. | HCV polipeptidek és HCV polinukleotidok, ilyen polinukleotidokat tartalmazó vektorok és ezekkel transzformált gazdasejtek, valamint HCV fertőzés kimutatására szolgáló diagnosztikumok és immunvizsgálati készlet |
WO1989012641A1 (en) * | 1988-06-17 | 1989-12-28 | Genelabs Incorporated | Enterically transmitted non-a/non-b hepatitis viral agent |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
SG48175A1 (en) * | 1989-07-25 | 1998-04-17 | Smithkline Beecham Biolog | Novel antigens and method for their preparation |
WO1991004262A1 (en) * | 1989-09-15 | 1991-04-04 | National Institute Of Health Of Japan | New hcv isolates |
IL97985A0 (en) * | 1990-05-07 | 1992-06-21 | North American Vaccine Inc | Improved vaccine compositions |
AU9052091A (en) * | 1990-12-20 | 1992-07-22 | Smithkline Beecham Biologicals (Sa) | Vaccines based on hepatitis b surface antigen |
-
1993
- 1993-03-23 MY MYPI93000533A patent/MY111880A/en unknown
- 1993-03-23 MA MA23137A patent/MA22842A1/fr unknown
- 1993-03-24 JP JP51704693A patent/JP3470719B2/ja not_active Expired - Lifetime
- 1993-03-24 NZ NZ249868A patent/NZ249868A/en not_active IP Right Cessation
- 1993-03-24 AT AT93906601T patent/ATE146678T1/de active
- 1993-03-24 AU AU37516/93A patent/AU3751693A/en not_active Abandoned
- 1993-03-24 EP EP93906601A patent/EP0633784B2/en not_active Expired - Lifetime
- 1993-03-24 UA UA94105947A patent/UA44688C2/uk unknown
- 1993-03-24 ES ES93906601T patent/ES2098029T5/es not_active Expired - Lifetime
- 1993-03-24 SG SG1996009183A patent/SG48375A1/en unknown
- 1993-03-24 RU RU94042386A patent/RU2121849C1/ru active
- 1993-03-24 KR KR1019940703355A patent/KR100270134B1/ko not_active IP Right Cessation
- 1993-03-24 SK SK1152-94A patent/SK280160B6/sk not_active IP Right Cessation
- 1993-03-24 DE DE69306940T patent/DE69306940T3/de not_active Expired - Lifetime
- 1993-03-24 DK DK93906601T patent/DK0633784T4/da active
- 1993-03-24 WO PCT/EP1993/000712 patent/WO1993019780A1/en active IP Right Grant
- 1993-03-24 CA CA002132833A patent/CA2132833C/en not_active Expired - Lifetime
- 1993-03-24 HU HU9402758A patent/HU221253B1/hu unknown
- 1993-03-24 CZ CZ942355A patent/CZ283424B6/cs not_active IP Right Cessation
- 1993-03-25 IL IL10516193A patent/IL105161A/en not_active IP Right Cessation
- 1993-03-25 AP APAP/P/1993/000502A patent/AP570A/en active
- 1993-03-26 CN CN93105232A patent/CN1072963C/zh not_active Expired - Lifetime
- 1993-03-26 SI SI9300149A patent/SI9300149B/sl unknown
- 1993-06-08 SA SA93130573A patent/SA93130573B1/ar unknown
-
1994
- 1994-09-26 FI FI944442A patent/FI110843B/fi not_active IP Right Cessation
- 1994-09-26 NO NO943571A patent/NO309458B1/no not_active IP Right Cessation
-
1996
- 1996-09-05 AU AU64457/96A patent/AU6445796A/en not_active Abandoned
- 1996-12-30 GR GR960403615T patent/GR3022174T3/el unknown
-
1998
- 1998-03-19 HK HK98102341A patent/HK1003218A1/xx unknown
-
1999
- 1999-06-10 AU AU33974/99A patent/AU3397499A/en not_active Abandoned
-
2002
- 2002-01-02 AU AU10008/02A patent/AU767755B2/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI9300149B (sl) | Sestavki cepiv | |
CA2212552C (en) | Hepatitis b vaccine | |
AP567A (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens. | |
JP5232006B2 (ja) | B型肝炎ウイルス表面抗原および界面活性剤の両方を含むワクチンの製造 | |
CZ390297A3 (cs) | Kombinovaná vakcína | |
SI9300335B (sl) | Vakcinski sestavek,ki obsega 3-DE-O-aciliran monofosforni lipid A in QS21 | |
ES2240647T7 (es) | Vacuna de pertussis acelular con toxoides de difteria y tetanos. | |
CA2347084C (en) | Hepatitis a vaccines | |
AU743759B2 (en) | Novel composition | |
US6488934B1 (en) | Hepatitis B vaccine | |
US7144703B2 (en) | Composition | |
PL174077B1 (pl) | Szczepionka do ochrony przed zakażeniem lub leczeniem zakażeń Hepatitis B i heterologicznych chorób, zawierająca antygen powierzchniowy Hepatitis B (HBsAg) | |
AU2012202099A1 (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens | |
MXPA97009732A (en) | Vaccine comprising a conjugate of antigen depolisacarido protein carrier and protein carrier li |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF | Valid on the event date |